Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidoreductase enzymes represent a large and diverse class (EC 1) of biological catalysts that facilitate oxidation-reduction (redox) reactions, transferring electrons between molecules. They are essential for energy generation, metabolic regulation, cellular redox balance, and detoxification of harmful species. Subtypes include dehydrogenases, oxidases, peroxidases, and oxygenases, each with specific substrate and acceptor profiles. Oxidoreductases often require cofactors such as NAD^+/NADP^+ or FAD. Due to their central role in metabolism, cell signaling, and defense against oxidative stress, oxidoreductases are key targets in drug discovery, diagnostic assays, and studies of disease mechanisms. Precision in naming (defining the exact enzyme) is crucial for clinical and research applications[1][3][10][6][9][12][11][13][15][2][5][7][8][16].
Electron donation/acceptance between substrates (redox reaction) Cofactor utilization (NAD^+/NADP^+, FAD) Detoxifying reactive oxygen species (peroxidases, catalases) Drug metabolism via oxidation/reduction
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidoreductase enzyme (EC 1).